Susquehanna International Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-72,300
Closed -$41.9K 13596
2024
Q3
$41.9K Buy
72,300
+3,400
+5% +$1.91K ﹤0.01% 11445
2024
Q2
$42.7K Sell
68,900
-295,300
-81% -$249K ﹤0.01% 11474
2024
Q1
$936K Buy
364,200
+310,700
+581% +$759K ﹤0.01% 7075
2023
Q4
$109K Buy
53,500
+8,200
+18% +$15K ﹤0.01% 11253
2023
Q3
$77.9K Buy
45,300
+27,400
+153% +$48.6K ﹤0.01% 11081
2023
Q2
$34.9K Sell
17,900
-22,500
-56% -$52.7K ﹤0.01% 11470
2023
Q1
$112K Buy
40,400
+15,300
+61% +$43.7K ﹤0.01% 11196
2022
Q4
$86.6K Sell
25,100
-31,400
-56% -$89.6K ﹤0.01% 11078
2022
Q3
$145K Buy
56,500
+1,400
+3% +$4.46K ﹤0.01% 11290
2022
Q2
$133K Sell
55,100
-52,000
-49% -$137K ﹤0.01% 11180
2022
Q1
$441K Buy
107,100
+71,100
+198% +$377K ﹤0.01% 9296
2021
Q4
$463K Sell
36,000
-280,900
-89% -$3.11M ﹤0.01% 9412
2021
Q3
$3.42M Buy
316,900
+285,200
+900% +$2.6M ﹤0.01% 4676
2021
Q2
$289K Buy
+31,700
New +$293K ﹤0.01% 10839

Other funds holding GRTS

Susquehanna International Group's GRTS Position: Q4 2024 in Review

Susquehanna International Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 204,780 shares — an estimated $119K sold.

Susquehanna International Group first reported a position in GRTS in Q2 2019 and held it in 16 quarters. The position peaked at $3.69M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Susquehanna International Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 204,780 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $119K.
  • Susquehanna International Group first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
  • Susquehanna International Group's Gritstone bio, Inc. Common Stock position peaked at $3.69M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.